You are here

Home

Research

Moderna says new Covid vaccine showed stronger immune response than current version --study

Tue, 2024-03-26 20:06 — mike kraft
Moderna says new Covid vaccine showed stronger immune response than current shot in study Moderna's new shot offers the potential of a longer shelf life and is one component of its combination vaccine targeting Covid and the flu. Annika Kim Constantino CNBC

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Disease Prevention
Health
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

U.S. FDA approves COVID preventive Pemgarda for immunocompromised persons

Tue, 2024-03-26 10:08 — mike kraft

 

FDA OKs Invivyd's COVID preventive Pemgarda for emergency use The pre-exposure treatment is indicated for adolescents and adults with moderate-to-severe immunocompromising conditions. CIDRAP

The Food and Drug Administration (FDA) on March 22 granted emergency use authorization (EUA) for Invivyd's monoclonal antibody to prevent COVID-19 in immunocompromised patients, which fills a gap following the withdrawal of Evusheld in January 2023.

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Treatments
Disease Prevention
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Covid lockdowns hit teenage boys the hardest --new study

Mon, 2024-03-25 10:31 — mike kraft
How Covid lockdowns hit mental health of teenage boys hardest New research findings are contrary to what had previously been thought about pandemic’s effect on children’s wellbeing The Guardian
Country / Region Tags: 
Global
UK - London
United Kingdom
General Topic Tags: 
COVID-19
Symptoms
Children
Data
Disease
Health
Pandemics
Research
Problem, Solution, SitRep, or ?: 
Analysis

Paxlovid outperforms molnupiravir against severe COVID-19 outcomes --study

Mon, 2024-03-25 10:16 — mike kraft

 

New data show Paxlovid outperforms molnupiravir against severe COVID-19 outcomes A large study yesterday in the International Journal of Infectious Diseases shows that, if prescribed within 5 days of confirmed infection, Paxlovid (nirmatrelvir-ritonavir) is more effective in protecting against all-cause mortality and severe COVID-19 in adults than is molnupiravir, another antiviral drug. CIDRAP

...

Country / Region Tags: 
Asia
China
Global
General Topic Tags: 
COVID-19
Treatments
Data
Disease
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Opinion: U.S. needs nonpartisan commission to examaine what wrong in dealing with early stages of COVID pandemic

Fri, 2024-03-22 19:30 — mike kraft
What Did the US Get Wrong During Covid? We Need to Know In the first year of the pandemic, leaders badly fumbled. We need a nonpartisan investigation into how things went so wrong. F.D. Flam Bloomberg

 

 

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Contagion
Disease Prevention
Government
Health
Medical Personnel
Mutations
Pandemics
Public Health
Research
Science
Social behavior
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

Millions at risk from cholera due to shortages of watern vaccines--WHO

Fri, 2024-03-22 19:08 — mike kraft
Millions at risk from cholera due to lack of clean water, soap and toilets, and shortage of cholera vaccine Immediate action is needed to stem an unprecedented multi-year upsurge in cholera cases worldwide, according to the International Coordinating Group (ICG) on Vaccine Provision.
Country / Region Tags: 
Africa
Global
Latin America
United Nations
General Topic Tags: 
Disease
Disease Prevention
Health
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Climate change increasing infectious disease threats, physicians caution

Fri, 2024-03-22 17:49 — mike kraft
Climate change unleashing torrent of infectious disease threats, physicians caution The shorter and milder winters, warming oceans, altered precipitation patterns, and extreme weather of climate change are fueling the spread of infectious diseases, experts warn today in JAMA. CIDRAP

...

Country / Region Tags: 
Global
General Topic Tags: 
Contagion
Disease
Health
Pandemics
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis

Flu linked to greater risk for neurological disorders than COVID-19-- study

Fri, 2024-03-22 10:10 — mike kraft
Flu linked to greater risk for neurological disorders than COVID-19, study shows - UPI.com The flu is more likely to lead to a neurological disorder than COVID-19, according to a new study that surprised its authors. UPI

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
Seasonal Flu
Symptoms
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

Native Americans are hit hardest by rising syphilis rates

Thu, 2024-03-21 11:12 — mike kraft
Rapid Rise in Syphilis Hits Native Americans Hardest - KFF Health News With U.S. syphilis rates climbing to the worst level in seven decades, public health experts and the federal Indian Health Service are scrambling to detect and treat the disease in Native American communities, where babies are infected at a higher rate than in any other demographic. khnkytjaw KFF Health News
Country / Region Tags: 
United States
General Topic Tags: 
Contagion
Symptoms
Children
Data
Demographics
Disease
Health
Public Health
Research
Science
Social behavior
Problem, Solution, SitRep, or ?: 
Situation Report

COVID related lung infection can damage heart--study

Thu, 2024-03-21 10:46 — mike kraft

 

COVID-induced lung infection linked to heart damage Severe acute respiratory distress syndrome (ARDS) related to COVID-19 infections can damage the heart even when the virus itself doesn’t affect heart tissue. The findings come from a study today in Circulation. CIDRAP

...

The study suggests that ARDS triggers widespread inflammation in the body, which leads to secondary cardiovascular complications.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Pages

Subscribe to Research
howdy folks